ArbiLayer
ALABON logo

Astera Labs (Ondo Tokenized)

ALABON Rank #6597
$351.96▲ 0.37%24h
Low $349.26High $352.06

Price chart

Loading price history…
Market cap$63.1KRank #6597
Fully diluted value$63.1K
Volume (24h)$151.7KVol / Mcap 240.24%
Circulating supply179.4096ALABON
Total supply179.4096
Max supply∞no hard cap
All-time high$500.29Jun 30, 2026
All-time low$243.66Jul 29, 2026

What is Astera Labs (Ondo Tokenized)?

Overview

ALABon provides non-US retail and institutional investors with exposure to Astera Labs Inc stock through tokenization. The product enables users to mint and redeem tokenized U.S. stocks and ETFs around the clock on weekdays, bypassing traditional geographic restrictions. Holders receive economic benefits equivalent to holding the underlying equity and reinvesting dividends.

How it works

ALABon is deployed across Ethereum, BNB Chain, and Solana blockchains, allowing cross-chain accessibility. Users can instantly mint and redeem tokens with access to traditional market liquidity. The tokenized structure provides 24/5 trading availability rather than standard stock market hours.

Token and supply

ALABon represents fractional ownership of Astera Labs Inc with economic exposure including dividend reinvestment. The token has a circulating supply of approximately 179 units with no maximum supply cap listed. Token mechanics are designed to track the underlying asset while enabling blockchain-based settlement and trading.

Where to trade ALABON

Exchanges that list this asset

All markets
#ExchangePairsVolume (24h)
Loading exchanges that list this asset…
Live spot quotes from connected exchanges
VenueBidAskMidStatus
Open to load live quotes.

ALABON funding rates

Live perpetual funding on every connected exchange. Positive = longs pay shorts.

Full view

Contracts & chains

Exact contract or mint per network — the identity layer used for DEX routing.

Resolving token registry…

On-chain routes

Networks with a connected DEX routing adapter.

Loading DEX coverage…

Astera Labs (Ondo Tokenized) news

All news
Loading related headlines…